Skip to main content

Dosing Considerations in Older Adults

  • Chapter
  • First Online:
Developing Drug Products in an Aging Society

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 26))

Abstract

Drug and dose selection in older adults is a complex process. Ensuring an optimal regimen may involve considerations beyond those that are immediately obvious. Factors affecting dosing in older adults vary across a wide spectrum and include changes to pharmacokinetics, pharmacodynamics, cognitive abilities, financial constraints, functional deficits, varying treatment-specific endpoints, and availability of evidence-based medicine. This chapter reviews these concepts and outlines the thought processes that clinicians should consider while making their dosing decisions. Recommendations to address these issues often include a combination of interventions and may require some creativity on behalf of the family, caregiver, and health care professionals. These factors should be considered during product development and could result in improved care of older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hughes GJ, Beizer JL. Appropriate prescribing. In: Ham RJ, Sloane PG, Warshaw GA, et al., editors. Ham’s primary care geriatrics: a case-based approach. 6th ed. Philadelphia: Elsevier; 2014. p. 67–76.

    Google Scholar 

  2. Carnahan RM, Lund BC, Perry PJ, et al. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481–6.

    Article  CAS  PubMed  Google Scholar 

  3. Semla TP, Beizer JL, Higbee MD. Geriatric dosage handbook. 20th ed. Hudson, Ohio: Lexi-Comp, Inc.; 2014.

    Google Scholar 

  4. American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227–46.

    Google Scholar 

  5. Delafuente JC. Pharmacokinetic and pharmacodynamic alterations in the geriatric patient. Consult Pharm. 2008;23(4):324–34.

    Article  PubMed  Google Scholar 

  6. Wedemeyer R-S, Blume H. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug Saf. 2014;37:201–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregory J. Hughes .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Hughes, G.J., Beizer, J.L. (2016). Dosing Considerations in Older Adults. In: Stegemann, S. (eds) Developing Drug Products in an Aging Society. AAPS Advances in the Pharmaceutical Sciences Series, vol 26. Springer, Cham. https://doi.org/10.1007/978-3-319-43099-7_14

Download citation

Publish with us

Policies and ethics